secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2022-03-23T23:59:59+00:00
Accession:  0001104659-22-037018
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics CFO Don Kalkofen resigns effective April 1, 2022
-------------------------------------------------------------------------

- CFO Don Kalkofen submitted resignation effective April 1, 2022.
- He will cease as principal financial and accounting officer upon resignation.
- Company has initiated a search for a replacement CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922037018/0001104659-22-037018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922037018/tm2210222d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-037018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer